Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

ambiotechadmin — Thu, 23 May 2024 23:48:33 +0000

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing renal fibrosis, involves the use of engineered extracellular vesicles.

Source

Renal Fibrosis – AM Biotech

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis